These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8740632)

  • 21. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
    Martins CA; Oulhaj A; de Jager CA; Williams JH
    Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
    Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
    Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOE ε4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death.
    Yu L; Boyle P; Schneider JA; Segawa E; Wilson RS; Leurgans S; Bennett DA
    Psychol Aging; 2013 Dec; 28(4):1015-23. PubMed ID: 23647000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele.
    Reed T; Carmelli D; Swan GE; Breitner JC; Welsh KA; Jarvik GP; Deeb S; Auwerx J
    Arch Neurol; 1994 Dec; 51(12):1189-92. PubMed ID: 7986172
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese.
    Mak YT; Chiu H; Woo J; Kay R; Chan YS; Hui E; Sze KH; Lum C; Kwok T; Pang CP
    Neurology; 1996 Jan; 46(1):146-9. PubMed ID: 8559364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.
    Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC
    Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias.
    Morris CM; Massey HM; Benjamin R; Leake A; Broadbent C; Griffiths M; Lamb H; Brown A; Ince PG; Tyrer S; Thompson P; McKeith IG; Edwardson JA; Perry RH; Perry EK
    J Neural Transm Suppl; 1996; 47():205-18. PubMed ID: 8841967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrovascular disease, APOE epsilon4 allele and cognitive decline in a cognitively normal population.
    Qiu C; Winblad B; Fratiglioni L
    Neurol Res; 2006 Sep; 28(6):650-6. PubMed ID: 16945218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E: non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease.
    Holmes C; Levy R; McLoughlin DM; Powell JF; Lovestone S
    J Neurol Neurosurg Psychiatry; 1996 Dec; 61(6):580-3. PubMed ID: 8971103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.
    Osuntokun BO; Sahota A; Ogunniyi AO; Gureje O; Baiyewu O; Adeyinka A; Oluwole SO; Komolafe O; Hall KS; Unverzagt FW
    Ann Neurol; 1995 Sep; 38(3):463-5. PubMed ID: 7668835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E polymorphism in elderly east Africans.
    Sayi JG; Patel NB; Premkumar DR; Adem A; Winblad B; Matuja WB; Mtui EP; Gatere S; Friedland RP; Koss E; Kalaria RN
    East Afr Med J; 1997 Oct; 74(10):668-70. PubMed ID: 9529753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals.
    Petersen RC; Smith GE; Ivnik RJ; Tangalos EG; Schaid DJ; Thibodeau SN; Kokmen E; Waring SC; Kurland LT
    JAMA; 1995 Apr; 273(16):1274-8. PubMed ID: 7646655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The apolipoprotein E epsilon 2 allele and decline in episodic memory.
    Wilson RS; Bienias JL; Berry-Kravis E; Evans DA; Bennett DA
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):672-7. PubMed ID: 12438469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E genotype and Alzheimer's disease in an elderly Norwegian cohort.
    Benjamin R; Leake A; McArthur FK; Candy JM; Ince PG; Edwardson JA; Torvik A; Morris CM; Bjertness E
    Neurodegeneration; 1996 Mar; 5(1):43-7. PubMed ID: 8731381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia.
    Gustafson L; Abrahamson M; Grubb A; Nilsson K; Fex G
    Dement Geriatr Cogn Disord; 1997; 8(4):240-3. PubMed ID: 9213069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
    Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia.
    Frisoni GB; Calabresi L; Geroldi C; Bianchetti A; D'Acquarica AL; Govoni S; Sirtori CR; Trabucchi M; Franceschini G
    Dementia; 1994; 5(5):240-2. PubMed ID: 7951679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
    Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Small GW; Roses AD; Haines JL; Pericak-Vance MA
    Science; 1993 Aug; 261(5123):921-3. PubMed ID: 8346443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein.
    Polvikoski T; Sulkava R; Haltia M; Kainulainen K; Vuorio A; Verkkoniemi A; Niinistö L; Halonen P; Kontula K
    N Engl J Med; 1995 Nov; 333(19):1242-7. PubMed ID: 7566000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.